[{"Assets_0_Q1_USD":8684359000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":62808000.0,"NetIncomeLossConverted_1_Q1_USD":685912000.0,"StockholdersEquity_0_Q1_USD":6293079000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":30196000.0,"EarningsPerShareBasic_1_Q1_USD":22.97,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":29865000.0,"EarningsPerShareDiluted_1_Q1_USD":22.72,"RevenuesConverted_1_Q1_USD":571644000.0,"Ticker":"BIO","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20200508"}]